Iranian Red Crescent Medical Journal

Published by: Kowsar

Stability of Renal Function in Spite of Low Glomerular Filtration Rate: A Case Report

Mohammad Reza Tamadon 1 , * and Seyed Seifollah Beladi Mousavi 2
Authors Information
1 Department of Internal Medicine, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, IR Iran
2 Chronic Renal Failure Research Center, Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: March 1, 2014, 17 (2); e21604
  • Published Online: January 25, 2015
  • Article Type: Case Report
  • Received: July 29, 2014
  • Revised: December 27, 2014
  • Accepted: December 31, 2014
  • DOI: 10.5812/ircmj.21604

To Cite: Tamadon M R, Beladi Mousavi S S. Stability of Renal Function in Spite of Low Glomerular Filtration Rate: A Case Report, Iran Red Crescent Med J. 2014 ; 17(2):e21604. doi: 10.5812/ircmj.21604.

Copyright © 2015, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Nesrallah GE, Mustafa RA, Clark WF, Bass A, Barnieh L, Hemmelgarn BR, et al. Canadian Society of Nephrology 2014 clinical practice guideline for timing the initiation of chronic dialysis. CMAJ. 2014; 186(2): 112-7[DOI][PubMed]
  • 2. Hajivandi A, Amiri M. World kidney day 2014: Kidney disease and elderly. J Parathyr Dis. 2014; 2(1): 3-4
  • 3. Nasri H. The awareness of chronic kidney disease and aging; the focus of world kidney day in 2014. J Nephropharmacol. 2014; 3(1): 1-2
  • 4. Nasri H. World kidney day 2013: acute kidney injury; a public health aware. Iran J Public Health. 2013; 42(3): 338-40[PubMed]
  • 5. Ardalan MR, Sanadgol H, Nasri H, Baradaran A, Rafieian-Kopaei M. Vitamin D therapy in diabetic kidney disease; current knowledge on a public health problem. J Parathyr Dis. 2014; 2(1): 15-7
  • 6. Tamadon MR. . Secondary hyperparathyroidism and chronic kidney disease. J Parathyr Dis. 2013; 1(1): 15-6
  • 7. Abboud H, Henrich WL. Stage IV Chronic Kidney Disease. N Engl J Med. 2010; 362(1): 56-65[DOI]
  • 8. Assadi F. The epidemic of pediatric chronic kidney disease: the danger of skepticism. J Nephropathol. 2012; 1(2): 61-4[DOI][PubMed]
  • 9. Roderick P, Roth M, Mindell J. Prevalence of chronic kidney disease in England: Findings from the 2009 Health Survey for England. J Epidemiol Community Health. 2011; 65[DOI]
  • 10. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003; 41(1): 1-12[DOI][PubMed]
  • 11. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013; 382(9888): 260-72[DOI][PubMed]
  • 12. Gowda S, Desai PB, Kulkarni SS, Hull VV, Math AA, Vernekar SN. Markers of renal function tests. N Am J Med Sci. 2010; 2(4): 170-3[PubMed]
  • 13. Amiri M, Nasri H. Secondary Hyperparathyroidism in chronic kidney disease patients. J Parathyr Dis. 2014; 2(1): 1-2
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments